Airainer, M. & Seifert, R. Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies. Naunyn Schmiedebergs Arch. Pharmacol. 397, 9723–9743 (2024).
Geddes, J. R., Burgess, S., Hawton, K., Jamison, K. & Goodwin, G. M. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am. J. Psychiatry 161, 217–222 (2004).
Baldessarini, R. J. et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 8, 625–639 (2006).
Puglisi-Allegra, S., Ruggieri, S. & Fornai, F. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. Transl. Psychiatry 11, 366 (2021).
Sanghani, H. R. et al. Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder. Mol. Psychiatry 26, 5252–5265 (2021).
McCarthy, M. J. et al. Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder. Neuropsychopharmacology 44, 620–628 (2019).
Mishra, H. K. et al. Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies. Mol. Psychiatry 26, 3383–3394 (2021).
Scott, J., Hennion, V., Meyrel, M., Bellivier, F. & Etain, B. An ecological study of objective rest-activity markers of lithium response in bipolar-I-disorder. Psychol. Med. 52, 2281–2289 (2022).
Malhi, G. S., Tanious, M., Das, P. & Berk, M. The science and practice of lithium therapy. Aust. N. Z. J. Psychiatry 46, 192–211 (2012).
Rybakowski, J. K. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. CNS Drugs 27, 165–173 (2013).
Pagani, R. et al. Twenty years of lithium pharmacogenetics: a systematic review. Psychiatry Res. 278, 42–50 (2019).
Patke, A., Young, M. W. & Axelrod, S. Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol. 21, 67–84 (2020).
Lane, J. M. et al. Genetics of circadian rhythms and sleep in human health and disease. Nat. Rev. Genet. 24, 4–20 (2023).
Banerjee, S. & Ray, S. Circadian medicine for aging attenuation and sleep disorders: prospects and challenges. Prog. Neurobiol. 220, 102387 (2023).
Logan, R. W. & McClung, C. A. Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat. Rev. Neurosci. 20, 49–65 (2019).
McCarthy, M. J. et al. Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: a critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. Bipolar Disord. 24, 232–263 (2022).
Bhatnagar, A., Murray, G. & Ray, S. Circadian biology to advance therapeutics for mood disorders. Trends Pharmacol. Sci. 44, 689–704 (2023).
Kramer, A. et al. Foundations of circadian medicine. PLoS Biol. 20, e3001567 (2022).
Hermida, R. C., Ayala, D. E., Chayan, L., Mojon, A. & Fernandez, J. R. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26, 61–79 (2009).
Sancar, A. & Van Gelder, R. N. Clocks, cancer and chronochemotherapy. Science 371, eabb0738 (2021).
Nahmias, Y. & Androulakis, I. P. Circadian effects of drug responses. Annu. Rev. Biomed. Eng. 23, 203–224 (2021).
Ruben, M. D., Smith, D. F., FitzGerald, G. A. & Hogenesch, J. B. Dosing time matters. Science 365, 547–549 (2019).
Cederroth, C. R. et al. Medicine in the fourth dimension. Cell Metab. 30, 238–250 (2019).
Lee, Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp. Mol. Med. 53, 1529–1538 (2021).
Pigazzani, F. et al. Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. EClin. Med. 72, 102633 (2024).
Bhatnagar, A. et al. Integrated bioinformatics and interaction analysis to advance chronotherapies for mental disorders. Front. Pharmacol. 15, 1444342 (2024).
Kling, M. A., Manowitz, P. & Pollack, I. W. Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotate. J. Pharm. Pharmacol. 30, 368–370 (1978).
Tondo, L. et al. Clinical use of lithium salts: guide for users and prescribers. Int. J. Bipolar Disord. 7, 16 (2019).
Wen, J., Sawmiller, D., Wheeldon, B. & Tan, J. A review for lithium: pharmacokinetics, drug design and toxicity. CNS Neurol. Disord. Drug Targets 18, 769–778 (2019).
Diamond, J. M., Ehrlich, B. E., Morawski, S. G., Santa Ana, C. A. & Fordtran, J. S. Lithium absorption in tight and leaky segments of intestine. J. Membr. Biol. 72, 153–159 (1983).
Finley, P. R. Drug interactions with lithium: an update. Clin. Pharmacokinet. 55, 925–941 (2016).
Fujikawa, R., Fujii, K. & Ozeki, Y. Patient with bipolar I disorder who presented with low blood lithium levels after receiving crushed tablets via a nasogastric tube: a case report. Front. Psychiatry 13, 1071721 (2022).
Thornhill, D. P. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage. Eur. J. Clin. Pharmacol. 14, 267–271 (1978).
Clarke, W. B., Guscott, R. & Lindstrom, R. M. Binding of lithium and boron to human plasma proteins II: results for a bipolar patient not on lithium therapy. Biol. Trace Elem. Res. 97, 117–124 (2004).
Telles-Correia, D. et al. Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity. World J. Gastrointest. Pharmacol. Ther. 8, 26–38 (2017).
Hayslett, J. P. & Kashgarian, M. A micropuncture study of the renal handling of lithium. Pflugers Arch. 380, 159–163 (1979).
Shirley, D. G., Walter, S. J. & Sampson, B. A micropuncture study of renal lithium reabsorption: effects of amiloride and furosemide. Am. J. Physiol. 263, F1128–F1133 (1992).
Trepiccione, F. & Christensen, B. M. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J. Nephrol. 23, S43–S48 (2010).
Malhi, G. S. & Tanious, M. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. CNS Drugs 25, 289–298 (2011).
Arancibia, A., Corvalan, F., Mella, F. & Concha, L. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations. Int. J. Clin. Pharmacol. Ther. Toxicol. 24, 240–245 (1986).
Koopman, M. G. et al. Circadian rhythm of glomerular filtration rate in normal individuals. Clin. Sci. (Lond.) 77, 105–111 (1989).
Ansermet, C. et al. The intrinsic circadian clock in podocytes controls glomerular filtration rate. Sci. Rep. 9, 16089 (2019).
Hillert, M., Zimmermann, M. & Klein, J. Uptake of lithium into rat brain after acute and chronic administration. Neurosci. Lett. 521, 62–66 (2012).
Renshaw, P. F. & Wicklund, S. In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol. Psychiatry 23, 465–475 (1988).
Plenge, P. et al. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol. Psychiatry 36, 511–516 (1994).
Cuddapah, V. A., Zhang, S. L. & Sehgal, A. Regulation of the blood-brain barrier by circadian rhythms and sleep. Trends Neurosci. 42, 500–510 (2019).
Zhang, S. L. et al. A circadian clock regulates efflux by the blood-brain barrier in mice and human cells. Nat. Commun. 12, 617 (2021).
Liška, K. et al. Lithium affects the circadian clock in the choroid plexus – a new role for an old mechanism. Biomed. Pharmacother. 159, 114292 (2023).
Iitaka, C., Miyazaki, K., Akaike, T. & Ishida, N. A role for glycogen synthase kinase-3β in the mammalian circadian clock. J. Biol. Chem. 280, 29397–29402 (2005).
Paul, J. R., Johnson, R. L., Jope, R. S. & Gamble, K. L. Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience 226, 1–9 (2012).
Klein, P. S. & Melton, D. A. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93, 8455–8459 (1996).
Firsov, D. & Bonny, O. Circadian rhythms and the kidney. Nat. Rev. Nephrol. 14, 626–635 (2018).
Nikolaeva, S. et al. Nephron-specific deletion of circadian clock gene Bmal1 alters the plasma and renal metabolome and impairs drug disposition. J. Am. Soc. Nephrol. 27, 2997–3004 (2016).
Cusin, C., Serretti, A., Mandelli, L., Lucca, A. & Smeraldi, E. Seasonal variations of lithium plasma levels. Psychiatry Res. 111, 35–41 (2002).
Medhi, B. et al. Seasonal variation in plasma levels of lithium in the Indian population: is there a need to modify the dose?. Singapore Med. J. 49, 724–727 (2008).
Chen, J. et al. Non-human primate seasonal transcriptome atlas reveals seasonal changes in physiology and diseases. Nat. Commun. 16, 3906 (2025).
Russell, W. et al. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J. Clin. Endocrinol. Metab. 93, 2300–2306 (2008).
Ikegami, K., Refetoff, S., Van Cauter, E. & Yoshimura, T. Interconnection between circadian clocks and thyroid function. Nat. Rev. Endocrinol. 15, 590–600 (2019).
Roelfsema, F. et al. Thyrotropin secretion in healthy subjects is robust and independent of age and gender, and only weakly dependent on body mass index. J. Clin. Endocrinol. Metab. 99, 570–578 (2014).
Kibirige, D., Luzinda, K. & Ssekitoleko, R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res. 6, 3 (2013).
Bocchetta, A. et al. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr. Scand. 94, 45–48 (1996).
Bocchetta, A. et al. Ten-year follow-up of thyroid function in lithium patients. J. Clin. Psychopharmacol. 21, 594–598 (2001).
Fairbrother, F., Petzl, N., Scott, J. G. & Kisely, S. Lithium can cause hyperthyroidism as well as hypothyroidism: a systematic review of an under-recognised association. Aust. N. Z. J. Psychiatry 53, 384–402 (2019).
Wilson, R. et al. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 34, 357–361 (1991).
Bellastella, G. et al. Chronothyroidology: chronobiological aspects in thyroid function and diseases. Life (Basel) 11, 426 (2021).
Hawkins, R., Kripke, D. F. & Janowsky, D. S. Circadian rhythm of lithium toxicity in mice. Psychopharmacology (Berl.) 56, 113–114 (1978).
Schou, M. et al. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology (Berl.) 77, 387–390 (1982).
Lauritsen, B. J. et al. Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance. Acta Psychiatr. Scand. 64, 314–319 (1981).
Kripke, D. F., Judd, L. L., Hubbard, B., Janowsky, D. S. & Huey, L. Y. The effect of lithium carbonate on the circadian rhythm of sleep in normal human subjects. Biol. Psychiatry 14, 545–548 (1979).
Johnsson, A., Pflug, B., Engelmann, W. & Klemke, W. Effect of lithium carbonate on circadian periodicity in humans. Pharmakopsychiatr. Neuropsychopharmakol. 12, 423–425 (1979).
Pflug, B. & Engelmann, W. Chronobiology of lithium–studies on healthy, middle-aged women. Pharmacopsychiatry 20, 181–188 (1987).
Xu, N., Yan, Y., Saunders, K. E. A., Geddes, J. R. & Browning, M. Effect of lithium on circadian activity level and flexibility in patients with bipolar disorder: results from the Oxford Lithium Trial. EBioMedicine 115, 105676 (2025).
Abe, M., Herzog, E. D. & Block, G. D. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 11, 3261–3264 (2000).
McEachron, D. L. et al. Lithium delays biochemical circadian rhythms in rats. Neuropsychobiology 8, 12–29 (1982).
Subramanian, P., Menon, V. P., Arokiam, F. V., Rajakrishnan, V. & Balamurugan, E. Lithium modulates biochemical circadian rhythms in Wistar rats. Chronobiol. Int. 15, 29–38 (1998).
Osland, T. M. et al. Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J. Psychopharmacol. 25, 924–933 (2011).
Li, J., Lu, W.-Q., Beesley, S., Loudon, A. S. I. & Meng, Q.-J. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS ONE 7, e33292 (2012).
McCarthy, M. J. et al. Genetic and clinical factors predict lithium’s effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl. Psychiatry 3, e318 (2013).
Etain, B., Meyrel, M., Hennion, V., Bellivier, F. & Scott, J. Can actigraphy be used to define lithium response dimensions in bipolar disorders?. J. Affect. Disord. 283, 402–409 (2021).
Murray, G. et al. Forecasting the course of bipolar disorder using rest-activity rhythms: protocol for a multi-study modelling project. Wellcome Open Res. 10, 320 (2025).
Reid, K. J. Assessment of circadian rhythms. Neurol. Clin. 37, 505–526 (2019).
Brown, L. S. et al. A classification approach to estimating human circadian phase under circadian alignment from actigraphy and photometry data. J. Pineal Res. 71, e12745 (2021).
Wittenbrink, N. et al. High-accuracy determination of internal circadian time from a single blood sample. J. Clin. Invest. 128, 3826–3839 (2018).
Murray, J. M. et al. A protocol to determine circadian phase by at-home salivary dim light melatonin onset assessment. J. Pineal Res. 76, e12994 (2024).
Lim, D. et al. Enhanced circadian phase tracking: a 5-h DLMO sampling protocol using wearable data. J. Biol. Rhythms 40, 249–261 (2025).
Roybal, K. et al. Mania-like behavior induced by disruption of CLOCK. Proc. Natl Acad. Sci. USA 104, 6406–6411 (2007).
Coyle, J. T. What can a clock mutation in mice tell us about bipolar disorder?. Proc. Natl Acad. Sci. USA 104, 6097–6098 (2007).
Wallace, M. L. et al. A translationally informed approach to vital signs for psychiatry: a preliminary proof of concept. NPP Digit. Psychiatry Neurosci. 2, 14 (2024).
Meyer, N. et al. The sleep-circadian interface: a window into mental disorders. Proc. Natl Acad. Sci. USA 121, e2214756121 (2024).
Baxi, E. G. et al. The breakthrough discoveries for thriving with bipolar disorder (BD2) integrated network longitudinal cohort protocol. Int. J. Bipolar Disord. 13, 36 (2025).
Wolpert, M., Bilsland, L., Boyce, N., Martin, K. & Sebastian, C. The Wellcome Trust: new funding for mental health science. World Psychiatry 22, 234–235 (2023).
Altamura, A. C., Gomeni, R., Sacchetti, E. & Smeraldi, E. Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. Eur. J. Clin. Pharmacol. 12, 59–63 (1977).
Chen, K.-P., Shen, W. W. & Lu, M.-L. Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin. Neurosci. 58, 25–29 (2004).
Besing, R. C. et al. Circadian rhythmicity of active GSK3 isoforms modulates molecular clock gene rhythms in the suprachiasmatic nucleus. J. Biol. Rhythms 30, 155–160 (2015).
Pizarro, A., Hayer, K., Lahens, N. F. & Hogenesch, J. B. CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res. 41, D1009–D1013 (2013).
Anafi, R. C., Francey, L. J., Hogenesch, J. B. & Kim, J. CYCLOPS reveals human transcriptional rhythms in health and disease. Proc. Natl Acad. Sci. USA 114, 5312–5317 (2017).
Lévi, F., Okyar, A., Dulong, S., Innominato, P. F. & Clairambault, J. Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 50, 377–421 (2010).
Puppala, A., Rankawat, S. & Ray, S. Circadian timekeeping in anticancer therapeutics: an emerging vista of chronopharmacology research. Curr. Drug Metab. 22, 998–1008 (2021).
Zhang, P. X. et al. A randomized phase II trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy. Chronobiol. Int. 35, 240–248 (2018).
Hermida, R. C., Ayala, D. E., Fernández, J. R. & Calvo, C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50, 715–722 (2007).
Wang, C. et al. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J. Clin. Hypertens. 15, 48–54 (2013).
Montaigne, D. et al. Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbα antagonism: a single-centre propensity-matched cohort study and a randomised study. Lancet 391, 59–69 (2018).
Burioka, N. et al. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal β2-adrenoceptor agonist tulobuterol chronotherapy. Chronobiol. Int. 22, 383–390 (2005).
Buttgereit, F. et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 371, 205–214 (2008).
Leave a Reply